STOCK TITAN

CIRTRAN CORP (CIRX) SEC Filings, Nov 14-20, 2025

CIRX OTC

CirTran Corporation filings document an OTC-traded Nevada operating company with common stock capital-structure activity and periodic reporting obligations. Its Form 10-K and Form 10-Q disclosures cover operating results, net sales, gross profit, expenses, and the company’s adult lifestyle and entertainment product business.

CirTran’s filing record also includes Form 8-K material-event reports for financing agreements, S-1 and S-1/A registration materials related to common stock disclosure, and Form 12b-25 notifications for delayed annual and quarterly reports. These documents describe financing terms, resale registration mechanics, reporting status, governance certifications, and recurring risk and liquidity matters.

Rhea-AI Summary

CirTran Corporation (CIRX) reported another quarterly loss and remains financially distressed. For the three months ended September 30, 2025, net sales rose to $448,492 from $256,070, mainly from stronger vapor product sales, lifting gross profit to $177,826. For the nine months, revenue was broadly flat at $1,077,743, while gross profit fell to $533,062 as costs increased.

The nine‑month net loss narrowed to $1,138,064 from $1,814,150, helped by lower derivative valuation losses, but interest expense of $612,219 and a derivative loss of $34,552 still weighed on results. Cash from operations was negative $1,031,790 and was covered largely by related‑party loans of $1,051,064.

At September 30, 2025, total assets were $1.9 million against liabilities of $27.5 million, including a working capital deficit of about $22.9 million, accumulated deficit of $62.8 million, and derivative liabilities of $2.49 million. Management states these conditions raise substantial doubt about the company’s ability to continue as a going concern, and disclosure controls and procedures were deemed not effective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

CirTran Corporation (CIRX) filed a Form 12b-25 (NT 10-Q), notifying a delay in its Quarterly Report for the period ended September 30, 2025. The company states it needs additional time to compile and analyze supporting documentation and to allow its independent registered public accounting firm to complete its review of the financial statements. CirTran indicates it intends to file the Form 10-Q as soon as possible.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many CIRTRAN (CIRX) SEC filings are available on StockTitan?

StockTitan tracks 12 SEC filings for CIRTRAN (CIRX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CIRTRAN (CIRX)?

The most recent SEC filing for CIRTRAN (CIRX) was filed on November 20, 2025.